Harmony Biosciences

+$1.13 (+2.66%) Today
-$1.64 (-3.76%) As of 8:05 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRMY and other ETFs, options, and stocks.

About HRMY

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors.

CEO
John C.s Jacobs
Employees
180
Headquarters
Plymouth Meeting, Pennsylvania
Founded
2017

HRMY Key Statistics

Market cap
2.58B
Price-Earnings ratio
52.77
Dividend yield
—
Average volume
405.05K
High today
$44.25
Low today
$42.35
Open price
$42.89
Volume
572.39K
52 Week high
$54.00
52 Week low
$25.09

HRMY Earnings

-$0.14
$0.12
$0.37
$0.63
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure